Jeffrey LAZARUS

Professor, ISGlobal, Barcelona, Spain

Prof Jeffrey V. LAZARUS (PhD, MIH, MA) is the Professor at the CUNY Graduate School of Public Health and Health Policy and the head of the Health Systems Research Group at the Barcelona Institute for Global Health (ISGlobal).

He is currently a member of the EASL Public Health and Policy Committee and an EASL 2024 mentor, and on the leadership committee of the Global NASH Council. He is chair of the Wilton Park NAFLD (now MASLD) meetings and co-chairs the annual Innovations in SLD Care Thinktank and as well as in 2023 the EASL SLD Summit and the Liver Connect NASH Connect.

He is the Principal Investigator (PI) of 10 active projects and trials and is the author of more than 400 publications including the NAFLD public health consensus statement (Nature Reviews GastroHep 2021), the new fatty liver disease nomenclature, published in 3 society journals (2023), the global NAFLD research (J Hepatology 2023) and action priorities (Hepatology 2023), the expert recommendation on NAFLD models of care (Nature Reviews GastroHep 2021), the fatty liver disease-Sustainable Development Goals score (Hepatology 2023), and the Global COVID-19 Consensus Statement (Nature 2022), and he is a co-author of the EASL NAFLD patient guideline (JHEP Reports 2021). He is on the editorial board of the Journal of Hepatology and Liver International.